• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对13 - 14岁儿童同时接种卡介苗、白喉 - 破伤风疫苗和口服脊髓灰质炎疫苗。

Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14.

作者信息

Galbraith N S, Crosby G, Barnes J M, Fernandes R

出版信息

Br Med J. 1971 Apr 24;2(5755):193-7. doi: 10.1136/bmj.2.5755.193.

DOI:10.1136/bmj.2.5755.193
PMID:5575951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1795324/
Abstract

The simultaneous administration of B.C.G. vaccine, diphtheria-tetanus toxoid aluminium hydroxide adsorbed vaccine, and oral poliovaccine was studied in 628 children aged 13-14 years between 1966 and 1969 in Newham, London. The efficacy of these vaccines was unaffected by administering them at the same time; routine simultaneous administration is considered justified when organizational difficulties prevent the attainment of high immunization rates with the vaccines given separately. No adverse reactions to B.C.G. or oral poliomyelitis vaccines took place, but 8% of children had moderately severe local reactions after diphtheria-tetanus aluminium hydroxide adsorbed vaccine, which were attributed to diphtheria toxoid.Serological studies showed the need for immunization against diphtheria, tetanus, and poliomyelitis at 13-14 years of age. Because of the adverse reactions to diphtheria toxoid, however, simultaneous administration of tetanus toxoid aluminium hydroxide adsorbed, oral poliomyelitis, and B.C.G. vaccines only is recommended at present.An "adult type" diphtheria-tetanus toxoid might overcome the problem of reactions, though in two to three years' time most children aged 13-14 years will have received diphtheria-tetanus-pertussis vaccine in infancy and reinforcement might then be accomplished by a small intradermal dose of the currently available fluid diphtheria-tetanus vaccine.Continued serological studies of diphtheria and tetanus antitoxins and polio antibody are necessary to determine the future need for reinforcement of immunity; such studies should become an essential part of the surveillance of the community immunization programme.

摘要

1966年至1969年期间,在伦敦纽汉姆对628名13至14岁的儿童进行了卡介苗、吸附白喉-破伤风类毒素氢氧化铝疫苗和口服脊髓灰质炎疫苗同时接种的研究。这些疫苗同时接种时其效力不受影响;当组织上的困难妨碍分别接种疫苗达到高免疫率时,常规同时接种被认为是合理的。未发生对卡介苗或口服脊髓灰质炎疫苗的不良反应,但8%的儿童在接种吸附白喉-破伤风氢氧化铝疫苗后出现中度严重的局部反应,这些反应归因于白喉类毒素。血清学研究表明13至14岁儿童有必要接种白喉、破伤风和脊髓灰质炎疫苗。然而,由于对白喉类毒素有不良反应,目前仅建议同时接种吸附破伤风类毒素氢氧化铝疫苗、口服脊髓灰质炎疫苗和卡介苗。一种“成人型”白喉-破伤风类毒素可能会解决反应问题,不过再过两到三年,大多数13至14岁的儿童在婴儿期已接种白喉-破伤风-百日咳疫苗,届时可通过皮内注射小剂量目前可用的液体白喉-破伤风疫苗来加强免疫。对白喉和破伤风抗毒素以及脊髓灰质炎抗体进行持续的血清学研究对于确定未来加强免疫的必要性是必要的;此类研究应成为社区免疫规划监测的重要组成部分。

相似文献

1
Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14.对13 - 14岁儿童同时接种卡介苗、白喉 - 破伤风疫苗和口服脊髓灰质炎疫苗。
Br Med J. 1971 Apr 24;2(5755):193-7. doi: 10.1136/bmj.2.5755.193.
2
Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.在韩国,一项比较联合使用无细胞百白破、灭活脊髓灰质炎(DTaP-IPV)疫苗与分别单独使用百白破(DTaP)和脊髓灰质炎(IPV)疫苗的免疫原性和安全性的随机对照研究:在婴儿中进行的研究。
Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.
3
Durability of immunity to diphtheria, tetanus and poliomyelitis after a three dose immunization schedule completed in the first eight months of life.
Vaccine. 1989 Aug;7(4):300-2. doi: 10.1016/0264-410x(89)90189-8.
4
Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen.在简化免疫程序中同时接种白喉-破伤风-百日咳-脊髓灰质炎和乙型肝炎疫苗:对白喉类毒素、破伤风类毒素、百日咳和乙型肝炎表面抗原的免疫反应。
Infect Immun. 1986 Mar;51(3):784-7. doi: 10.1128/iai.51.3.784-787.1986.
5
Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.吸附型低剂量白喉、破伤风和灭活脊髓灰质炎联合疫苗(REVAXIS(®))与白喉、破伤风和灭活脊髓灰质炎联合疫苗(DT Polio(®))在6岁时作为加强剂量接种的免疫原性和安全性比较
Hum Vaccin. 2011 May;7(5):549-56. doi: 10.4161/hv.7.5.14982. Epub 2011 May 1.
6
SMALLPOX, DIPHTHERIA, TETANUS, PERTUSSIS, AND POLIOMYELITIS IMMUNIZATION.天花、白喉、破伤风、百日咳和脊髓灰质炎免疫接种
JAMA. 1964 Mar 28;187:1009-12. doi: 10.1001/jama.1964.03060260037008.
7
Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.在接种史不明的成人中,于吸附无细胞百白破-灭活脊髓灰质炎疫苗(REVAXIS®)接种后1个月接种吸附无细胞百白破-灭活脊髓灰质炎疫苗(REPEVAX®)的体液免疫。
Hum Vaccin. 2010 Oct;6(10):829-34. doi: 10.4161/hv.6.10.12582. Epub 2010 Oct 1.
8
CURRENT IMMUNIZATION METHODS AND PRECAUTIONS.当前的免疫接种方法及预防措施。
Calif Med. 1964 Sep;101(3):153-9.
9
Vaccination in infancy with oral poliomyelitis vaccine and diphtheria, tetanus, pertussis vaccine.婴儿期口服脊髓灰质炎疫苗以及白喉、破伤风、百日咳疫苗的接种。
Br Med J. 1963 Mar 9;1(5331):641-3. doi: 10.1136/bmj.1.5331.641.
10
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III.
Vaccine. 1996 Sep;14(13):1265-72. doi: 10.1016/s0264-410x(96)00092-8.

引用本文的文献

1
Quality management in the NHS: the doctor's role--II.英国国民医疗服务体系中的质量管理:医生的角色——第二部分。
BMJ. 1992 Feb 1;304(6822):304-8. doi: 10.1136/bmj.304.6822.304.

本文引用的文献

1
Rubella-virus hemagglutination-inhibition test.风疹病毒血凝抑制试验
N Engl J Med. 1967 Mar 9;276(10):554-7. doi: 10.1056/NEJM196703092761006.
2
Reinforcing doses of diphtheria toxoid in children aged 10 to 12 years. Inadequate response to a single dose of orally administered toxoid.10至12岁儿童白喉类毒素强化剂量。对单剂量口服类毒素反应不足。
Mon Bull Minist Health Public Health Lab Serv. 1966 May;25:110-5.
3
Polioantibody titres in children aged 7-15 years in London.伦敦7至15岁儿童的脊髓灰质炎抗体滴度
Lancet. 1969 Oct 11;2(7624):792-3. doi: 10.1016/s0140-6736(69)90496-6.